Colgate-Palmolive (NYSE:CL) Shares Bought by Natixis Advisors L.P.

Natixis Advisors L.P. lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 28.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 199,985 shares of the company’s stock after purchasing an additional 44,122 shares during the quarter. Natixis Advisors L.P.’s holdings in Colgate-Palmolive were worth $15,940,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of CL. Vest Financial LLC raised its position in Colgate-Palmolive by 25.1% in the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after acquiring an additional 74,337 shares in the last quarter. Central Bank & Trust Co. boosted its holdings in Colgate-Palmolive by 22.1% during the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after buying an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC grew its position in Colgate-Palmolive by 9.2% in the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after buying an additional 910 shares during the last quarter. Sarasin & Partners LLP increased its holdings in shares of Colgate-Palmolive by 1.2% in the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after buying an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC lifted its position in shares of Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after acquiring an additional 172 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL opened at $93.18 on Tuesday. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $93.30. The stock has a fifty day moving average price of $88.49 and a 200 day moving average price of $82.49. The stock has a market cap of $76.45 billion, a price-to-earnings ratio of 29.49, a PEG ratio of 3.43 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm’s revenue was up 6.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.73 EPS. Analysts forecast that Colgate-Palmolive will post 3.52 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.15%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CL. Citigroup lifted their target price on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Morgan Stanley lifted their target price on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. The Goldman Sachs Group assumed coverage on shares of Colgate-Palmolive in a research report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target for the company. Finally, Evercore ISI lifted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $91.44.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the transaction, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, insider Jennifer Daniels sold 5,790 shares of the firm’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.96, for a total value of $486,128.40. Following the transaction, the insider now directly owns 63,236 shares in the company, valued at approximately $5,309,294.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the transaction, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. In the last 90 days, insiders sold 159,048 shares of company stock valued at $13,336,846. Insiders own 0.37% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.